Evidence for the PGD2/PGF2 phenotype being driven by microglial C3AR1 activation via tumor-expressed CFB/C3 generating C3a is found by examining the phenotypical differences between the tumors that generate PGD2, PGF2, and PGE2, as shown in Figure 4. The gene discussed is C3; the disease is neoplasm.